|
1）Kong L, Giang E, Nieusma T, et al. Hepatitis C virus E2 envelope glycoprotein core structure. Science. 2013; 342: 1090-4
|
|
|
|
2）Khan AG, Whidby J, Miller MT, et al. Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2. Nature. 2014; 509: 381-4
|
|
|
|
|
|
3）El Omari K, Iourin O, Kadlec J, et al. Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1. Nat Commun. 2014; 5: 4874
|
|
|
|
|
|
4）Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005; 11: 791-6
|
|
|
|
|
|
5）Yi M, Villanueva RA, Thomas DL, et al. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A. 2006; 103: 2310-5
|
|
|
|
|
|
6）Yi M, Lemon SM. Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells. J Virol. 2004; 78: 7904-15
|
|
|
|
|
|
7）Yamane D, McGivern DR, Wauthier E, et al. Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nat Med. 2014; 20: 927-35
|
|
|
|
|
|
8）Li YP, Ramirez S, Jensen SB, et al. Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system. Proc Natl Acad Sci U S A. 2012; 109: 19757-62
|
|
|
|
|
|
9）Date T, Kato T, Kato J, et al. Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone. J Virol. 2012; 86: 10805-20
|
|
|
|
|
|
10）Li YP, Ramirez S, Gottwein JM, et al. Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains. Proc Natl Acad Sci U S A. 2012; 109: E1101-10
|
|
|
|
|
|
11）Ramirez S, Li YP, Jensen SB, et al. Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors. Hepatology. 2014; 59: 395-407
|
|
|
|
|
|
12）Saeed M, Gondeau C, Hmwe S, et al. Replication of hepatitis C virus genotype 3a in cultured cells. Gastroenterology. 2013; 144: 56-8. e7
|
|
|
|
|
|
13）Kim S, Date T, Yokokawa H, et al. Development of hepatitis C virus genotype 3a cell culture system. Hepatology. 2014; 60: 1838-50
|
|
|
|
|
|
14）Dorner M, Horwitz JA, Robbins JB, et al. A genetically humanized mouse model for hepatitis C virus infection. Nature. 2011; 474: 208-11
|
|
|
|
|
|
15）Dorner M, Horwitz JA, Donovan BM, et al. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature. 2013; 501: 237-41
|
|
|
|
|
|
16）Aly HH, Oshiumi H, Shime H, et al. Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV). PLoS One. 2011; 6: e21284
|
|
|
|
|
|
17）Yoshida T, Takayama K, Kondoh M, et al. Use of human hepatocyte-like cells derived from induced pluripotent stem cells as a model for hepatocytes in hepatitis C virus infection. Biochem Biophys Res Commun. 2011; 416: 119-24
|
|
|
|
|
|
18）Schwartz RE, Trehan K, Andrus L, et al. Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012; 109: 2544-8
|
|
|
|
|
|
19）Roelandt P, Obeid S, Paeshuyse J, et al. Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J Hepatol. 2012; 57: 246-51
|
|
|
|
|
|
20）Wu X, Robotham JM, Lee E, et al. Productive hepatitis C virus infection of stem cell-derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog. 2012; 8: e1002617
|
|
|
|
|
|
21）Sourisseau M, Goldman O, He W, et al. Hepatic cells derived from induced pluripotent stem cells of pigtail macaques support hepatitis C virus infection. Gastroenterology. 2013; 145: 966-9. e7
|
|
|
|
|